Mapping knowledge domains analysis of pancreatic neuroendocrine neoplasm research based on CiteSpace_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

HUANG Zixing , LI Mou , YU Haopeng , WANG Yi ,  SONG Bin

Department of Radiology, West China Hospital, Sichuan University, Chengdu 610041, P. R. China;

Corresponding author：

SONG Bin, Email: cjr.songbin@vip.163.com

Keywords：

pancreatic neuroendocrine neoplasm; pancreatic neuroendocrine tumor; diagnostic imaging; bibliometric analysis; science mapping; knowledge domain visualization; domain analysis; CiteSpace software

DOI：

10.7507/1007-9424.201812007

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To investigate current status and hot issues of pancreatic neuroendocrine neoplasm (pNEN) imaging research.Methods The literatures focusing on pNEN and published from 1998 to 2018 were retrieved from the core database of Web of Science. The quantitative analysis of literatures was then conducted by using the CiteSpace software based on the bibliometrics method. The research trend was then summarized systematically and the potential research fronts and focuses were explored.Results A total of 190 articles in the field of pNEN imaging research were retrieved, and the top three countries in the literatures were the United States, Germany, and Italy. The clustering of co-citation of pNEN included the endoscopic ultrasound, current diagnosis, prospective evaluation, cystic pancreatic neuroendocrine tumor, hypervascular neuroendocrine tumor, nonfunctioning pancreatic neuroendocrine tumor, intravoxel incoherent motion, and metastastic lesion. The hot of keywords in the field of pNEN included the fine needle aspiration, CT, diagnosis, pancreas, cancer, neuroendocrine tumor, neoplasm, carcinoma, and management. The hot keywords clustering had the neuroendocrine tumor, pancreatic mass size, non-hyperfunctioning neuroendocrine tumor, CT appearance, metastatic lesion, ancillary studies, somatostatin analogues, somatostatinoma, intraoperative ultrasound, and multiple endcorine neoplasia 1.Conclusion Accurate imaging diagnosis of pNEN is still a hot issue in this field.

Citation： HUANG Zixing, LI Mou, YU Haopeng, WANG Yi, SONG Bin. Mapping knowledge domains analysis of pancreatic neuroendocrine neoplasm research based on CiteSpace. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2019, 26(1): 96-101. doi: 10.7507/1007-9424.201812007 Copy

1.	陈悦, 刘则渊. 悄然兴起的科学知识图谱. 科学学研究, 2005, 23(2): 149-154.
2.	陈悦, 陈超美, 刘则渊, 等. CiteSpace知识图谱的方法论功能. 科学学研究, 2015, 33(2): 242-253.
3.	Hallet J, Law CH, Cukier M, et al. Exploring the rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation, and outcomes. Cancer, 2015, 121(4): 589-97.
4.	中国临床肿瘤学会神经内分泌肿瘤专家委员会. 中国胃肠胰神经内分泌肿瘤专家共识(2016年版). 临床肿瘤学杂志, 2016, 21(10): 927-946.
5.	Klimstra DS. Pathologic classification of neuroendocrine neoplasms. Hematol Oncol Clin North Am, 2016, 30(1): 1-19.
6.	Kleinberg J. Bursty and hierarchical structure in streams. Data Min Knowl Discov, 2003, 7(4): 373-397.
7.	Brugge WR, Lewandrowski K, Lee-Lewandrowski E, et al. Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study. Gastroenterology, 2004, 126(5): 1330-1336.
8.	Voss M, Hammel P, Molas G, et al. Value of endoscopic ultrasound guided fine needle aspiration biopsy in the diagnosis of solid pancreatic masses. Gut, 2000, 46(2): 244-249.
9.	Anderson MA, Carpenter S, Thompson NW, et al. Endoscopic ultrasound is highly accurate and directs management in patients with neuroendocrine tumors of the pancreas. Am J Gastroenterol, 2000, 95(9): 2271-2277.
10.	Eloubeidi MA, Jhala D, Chhieng DC, et al. Yield of endoscopic ultrasound-guided fine-needle aspiration biopsy in patients with suspected pancreatic carcinoma. Cancer, 2003, 99(5): 285-292.
11.	Goldberg SN, Mallery S, Gazelle GS, et al. EUS-guided radio-frequency ablation in the pancreas: results in a porcine model. Gastrointest Endosc, 1999, 50(3): 392-401.
12.	Wang D, Zhang GB, Yan L, et al. CT and enhanced CT in diagnosis of gastrointestinal neuroendocrine carcinomas. Abdom Imaging, 2012, 37(5): 738-745.
13.	Chen C, Chen Y, Horowitz M, et al. Towards an explanatory and computational theory of scientific discovery. J Informetrics, 2009, 3(3): 191-209.
14.	Chen C. Science MAPPING: a systematic review of the literature. J Data Inf Sci, 2017, 2(2): 1-40.
15.	Rindi G, Petrone G, Inzani F. The 2010 WHO classification of digestive neuroendocrine neoplasms: a critical appraisal four years after its introduction. Endocr Pathol, 2014, 25(2): 186-192.
16.	张雨晴, 马莉, 贺宇彤, 等. 2001~2010年中国胰腺神经内分泌肿瘤的临床流行病学特征分析. 中国肿瘤, 2016, 25(5): 329-333.
17.	张雨晴, 范金虎. 中国胃肠胰腺神经内分泌肿瘤的十年回顾性临床流行病学研究. 公共卫生, 2016.
18.	O’Regan D, Tait P. Imaging of the pancreas. Br J Hosp Med (Lond), 2006, 67(1): 8-13.
19.	Tamm EP, Bhosale P, Lee JH, et al. State-of-the-art imaging of pancreatic neuroendocrine tumors. Surg Oncol Clin N Am, 2016, 25(2): 375-400.
20.	Lee L, Ito T, Jensen RT. Imaging of pancreatic neuroendocrine tumors: recent advances, current status, and controversies. Expert Rev Anticancer Ther, 2018, 18(9): 837-860.
21.	陈曦, 周光文. 胰腺神经内分泌肿瘤诊治热点探讨. 中国普外基础与临床杂志, 2012, 19(10): 1033-1038.
22.	刘曦娇, 王威亚, 黄子星, 等. 胰腺神经内分泌癌的影像学表现. 中国普外基础与临床杂志, 2012, 19(10): 1126-1129.
23.	Kang KM, Lee JM, Yoon JH, et al. Intravoxel incoherent motion diffusion-weighted MR imaging for characterization of focal pancreatic lesions. Radiology, 2014, 270(2): 444-453.
24.	Concia M, Sprinkart AM, Penner AH, et al. Diffusion-weighted magnetic resonance imaging of the pancreas: diagnostic benefit from an intravoxel incoherent motion model-based 3 b-value analysis. Invest Radiol, 2014, 49(2): 93-100.
25.	Kim B, Lee SS, Sung YS, et al. Intravoxel incoherent motion diffusion-weighted imaging of the pancreas: Characterization of benign and malignant pancreatic pathologies. J Magn Reson Imaging, 2017, 45(1): 260-269.
26.	Park HJ, Jang KM, Song KD, et al. Value of unenhanced MRI with diffusion-weighted imaging for detection of primary small (≤20 mm) solid pancreatic tumours and prediction of pancreatic ductal adenocarcinoma. Clin Radiol, 2017, 72(12): 1076-1084.
27.	Krishna SG, Bhattacharya A, Ross WA, et al. Pretest prediction and diagnosis of metastatic lesions to the pancreas by endoscopic ultrasound-guided fine needle aspiration. J Gastroenterol Hepatol, 2015, 30(10): 1552-1560.
28.	Boy C, Heusner TA, Poeppel TD, et al. 68Ga-DOTATOC PET/CT and somatostatin receptor (sst1-sst5) expression in normal human tissue: correlation of sst2 mRNA and SUVmax. Eur J Nucl Med Mol Imaging, 2011, 38(7): 1224-1236.
29.	Krausz Y, Rubinstein R, Appelbaum L, et al. Ga-68 DOTA-NOC uptake in the pancreas: pathological and physiological patterns. Clin Nucl Med, 2012, 37(1): 57-62.
30.	Haug AR, Cindea-Drimus R, Auernhammer CJ, et al. The role of 68Ga-DOTATATE PET/CT in suspected neuroendocrine tumors. J Nucl Med, 2012, 53(11): 1686-1692.
31.	Sowa-Staszczak A, Pach D, Mikołajczak R, et al. Glucagon-like peptide-1 receptor imaging with[Lys⁴⁰(Ahx-HYNIC-^99mTc/EDDA)NH₂]-exendin-4 for the detection of insulinoma. Eur J Nucl Med Mol Imaging, 2013, 40(4): 524-531.
32.	Schmid-Tannwald C, Schmid-Tannwald CM, Morelli JN, et al. Comparison of abdominal MRI with diffusion-weighted imaging to ⁶⁸Ga-DOTATATE PET/CT in detection of neuroendocrine tumors of the pancreas. Eur J Nucl Med Mol Imaging, 2013, 40(6): 897-907.
33.	Sharma P, Mukherjee A, Karunanithi S, et al. Accuracy of ⁶⁸Ga DOTANOC PET/CT imaging in patients with multiple endocrine neoplasia syndromes. Clin Nucl Med, 2015, 40(7): e351-e356.
34.	Lee I, Paeng JC, Lee SJ, et al. Comparison of diagnostic sensitivity and quantitative indices between⁶⁸Ga-DOTATOC PET/CT and ¹¹¹In-pentetreotide SPECT/CT in neuroendocrine tumors: a preliminary report. Nucl Med Mol Imaging, 2015, 49(4): 284-290.
35.	Sharma P, Arora S, Dhull VS, et al. Evaluation of ⁶⁸Ga-DOTANOC PET/CT imaging in a large exclusive population of pancreatic neuroendocrine tumors. Abdom Imaging, 2015, 40(2): 299-309.
36.	Ruf J, von Wedel F, Furth C, et al. Significance of a single-time-point somatostatin receptor SPECT/multiphase CT protocol in the diagnostic work-up of gastroenteropancreatic neuroendocrine neoplasms. J Nucl Med, 2016, 57(2): 180-185.
37.	Arıcan P, Okudan Tekin B, Naldöken S, et al. A family with von Hippel-Lindau syndrome: the findings of indium-111 somatostatin receptor scintigraphy, iodine-123 metaiodobenzylguanidine scintigraphy and single photon emission computerized tomography. Mol Imaging Radionucl Ther, 2017, 26(1): 38-42.
38.	Tshori S, Bocher M, Yuzefovich B, et al. Diagnostic computed tomography coregistration with In-111-DTPA-octreotide single photon emission tomography/low-dose computed tomography. J Comput Assist Tomogr, 2017, 41(3): 499-504.
39.	Lee NJ, Hruban RH, Fishman EK. Pancreatic neuroendocrine tumor: review of heterogeneous spectrum of CT appearance. Abdom Radiol (NY), 2018, 43(11): 3025-3034.
40.	Choi TW, Kim JH, Yu MH, et al. Pancreatic neuroendocrine tumor: prediction of the tumor grade using CT findings and computerized texture analysis. Acta Radiol, 2018, 59(4): 383-392.
41.	Zhu L, Xue H, Sun H, et al. Insulinoma detection with MDCT: is there a role for whole-pancreas perfusion? AJR Am J Roentgenol, 2017, 208(2): 306-314.
42.	Paiella S, Impellizzeri H, Zanolin E, et al. Comparison of imaging-based and pathological dimensions in pancreatic neuroendocrine tumors. World J Gastroenterol, 2017, 23(17): 3092-3098.
43.	Tatsas AD, Owens CL, Siddiqui MT, et al. Fine-needle aspiration of intrapancreatic accessory spleen: cytomorphologic features and differential diagnosis. Cancer Cytopathol, 2012, 120(4): 261-268.
44.	Atiq M, Bhutani MS, Bektas M, et al. EUS-FNA for pancreatic neuroendocrine tumors: a tertiary cancer center experience. Dig Dis Sci, 2012, 57(3): 791-800.
45.	Mahajan R, Simon EG, Chacko A, et al. Endoscopic ultrasonography in pediatric patients—Experience from a tertiary care center in India. Indian J Gastroenterol, 2016, 35(1): 14-19.
46.	Krishna SG, Bhattacharya A, Li F, et al. Diagnostic differentiation of pancreatic neuroendocrine tumor from other neoplastic solid pancreatic lesions during endoscopic ultrasound-guided fine-needle aspiration. Pancreas, 2016, 45(3): 394-400.
47.	Bergeron JP, Perry KD, Houser PM, et al. Endoscopic ultrasound-guided pancreatic fine-needle aspiration: potential pitfalls in one institution’s experience of 1 212 procedures. Cancer Cytopathol, 2015, 123(2): 98-107.

1. 陈悦, 刘则渊. 悄然兴起的科学知识图谱. 科学学研究, 2005, 23(2): 149-154.
2. 陈悦, 陈超美, 刘则渊, 等. CiteSpace知识图谱的方法论功能. 科学学研究, 2015, 33(2): 242-253.
3. Hallet J, Law CH, Cukier M, et al. Exploring the rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation, and outcomes. Cancer, 2015, 121(4): 589-97.
4. 中国临床肿瘤学会神经内分泌肿瘤专家委员会. 中国胃肠胰神经内分泌肿瘤专家共识(2016年版). 临床肿瘤学杂志, 2016, 21(10): 927-946.
5. Klimstra DS. Pathologic classification of neuroendocrine neoplasms. Hematol Oncol Clin North Am, 2016, 30(1): 1-19.
6. Kleinberg J. Bursty and hierarchical structure in streams. Data Min Knowl Discov, 2003, 7(4): 373-397.
7. Brugge WR, Lewandrowski K, Lee-Lewandrowski E, et al. Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study. Gastroenterology, 2004, 126(5): 1330-1336.
8. Voss M, Hammel P, Molas G, et al. Value of endoscopic ultrasound guided fine needle aspiration biopsy in the diagnosis of solid pancreatic masses. Gut, 2000, 46(2): 244-249.
9. Anderson MA, Carpenter S, Thompson NW, et al. Endoscopic ultrasound is highly accurate and directs management in patients with neuroendocrine tumors of the pancreas. Am J Gastroenterol, 2000, 95(9): 2271-2277.
10. Eloubeidi MA, Jhala D, Chhieng DC, et al. Yield of endoscopic ultrasound-guided fine-needle aspiration biopsy in patients with suspected pancreatic carcinoma. Cancer, 2003, 99(5): 285-292.
11. Goldberg SN, Mallery S, Gazelle GS, et al. EUS-guided radio-frequency ablation in the pancreas: results in a porcine model. Gastrointest Endosc, 1999, 50(3): 392-401.
12. Wang D, Zhang GB, Yan L, et al. CT and enhanced CT in diagnosis of gastrointestinal neuroendocrine carcinomas. Abdom Imaging, 2012, 37(5): 738-745.
13. Chen C, Chen Y, Horowitz M, et al. Towards an explanatory and computational theory of scientific discovery. J Informetrics, 2009, 3(3): 191-209.
14. Chen C. Science MAPPING: a systematic review of the literature. J Data Inf Sci, 2017, 2(2): 1-40.
15. Rindi G, Petrone G, Inzani F. The 2010 WHO classification of digestive neuroendocrine neoplasms: a critical appraisal four years after its introduction. Endocr Pathol, 2014, 25(2): 186-192.
16. 张雨晴, 马莉, 贺宇彤, 等. 2001~2010年中国胰腺神经内分泌肿瘤的临床流行病学特征分析. 中国肿瘤, 2016, 25(5): 329-333.
17. 张雨晴, 范金虎. 中国胃肠胰腺神经内分泌肿瘤的十年回顾性临床流行病学研究. 公共卫生, 2016.
18. O’Regan D, Tait P. Imaging of the pancreas. Br J Hosp Med (Lond), 2006, 67(1): 8-13.
19. Tamm EP, Bhosale P, Lee JH, et al. State-of-the-art imaging of pancreatic neuroendocrine tumors. Surg Oncol Clin N Am, 2016, 25(2): 375-400.
20. Lee L, Ito T, Jensen RT. Imaging of pancreatic neuroendocrine tumors: recent advances, current status, and controversies. Expert Rev Anticancer Ther, 2018, 18(9): 837-860.
21. 陈曦, 周光文. 胰腺神经内分泌肿瘤诊治热点探讨. 中国普外基础与临床杂志, 2012, 19(10): 1033-1038.
22. 刘曦娇, 王威亚, 黄子星, 等. 胰腺神经内分泌癌的影像学表现. 中国普外基础与临床杂志, 2012, 19(10): 1126-1129.
23. Kang KM, Lee JM, Yoon JH, et al. Intravoxel incoherent motion diffusion-weighted MR imaging for characterization of focal pancreatic lesions. Radiology, 2014, 270(2): 444-453.
24. Concia M, Sprinkart AM, Penner AH, et al. Diffusion-weighted magnetic resonance imaging of the pancreas: diagnostic benefit from an intravoxel incoherent motion model-based 3 b-value analysis. Invest Radiol, 2014, 49(2): 93-100.
25. Kim B, Lee SS, Sung YS, et al. Intravoxel incoherent motion diffusion-weighted imaging of the pancreas: Characterization of benign and malignant pancreatic pathologies. J Magn Reson Imaging, 2017, 45(1): 260-269.
26. Park HJ, Jang KM, Song KD, et al. Value of unenhanced MRI with diffusion-weighted imaging for detection of primary small (≤20 mm) solid pancreatic tumours and prediction of pancreatic ductal adenocarcinoma. Clin Radiol, 2017, 72(12): 1076-1084.
27. Krishna SG, Bhattacharya A, Ross WA, et al. Pretest prediction and diagnosis of metastatic lesions to the pancreas by endoscopic ultrasound-guided fine needle aspiration. J Gastroenterol Hepatol, 2015, 30(10): 1552-1560.
28. Boy C, Heusner TA, Poeppel TD, et al. 68Ga-DOTATOC PET/CT and somatostatin receptor (sst1-sst5) expression in normal human tissue: correlation of sst2 mRNA and SUVmax. Eur J Nucl Med Mol Imaging, 2011, 38(7): 1224-1236.
29. Krausz Y, Rubinstein R, Appelbaum L, et al. Ga-68 DOTA-NOC uptake in the pancreas: pathological and physiological patterns. Clin Nucl Med, 2012, 37(1): 57-62.
30. Haug AR, Cindea-Drimus R, Auernhammer CJ, et al. The role of 68Ga-DOTATATE PET/CT in suspected neuroendocrine tumors. J Nucl Med, 2012, 53(11): 1686-1692.
31. Sowa-Staszczak A, Pach D, Mikołajczak R, et al. Glucagon-like peptide-1 receptor imaging with[Lys⁴⁰(Ahx-HYNIC-^99mTc/EDDA)NH₂]-exendin-4 for the detection of insulinoma. Eur J Nucl Med Mol Imaging, 2013, 40(4): 524-531.
32. Schmid-Tannwald C, Schmid-Tannwald CM, Morelli JN, et al. Comparison of abdominal MRI with diffusion-weighted imaging to ⁶⁸Ga-DOTATATE PET/CT in detection of neuroendocrine tumors of the pancreas. Eur J Nucl Med Mol Imaging, 2013, 40(6): 897-907.
33. Sharma P, Mukherjee A, Karunanithi S, et al. Accuracy of ⁶⁸Ga DOTANOC PET/CT imaging in patients with multiple endocrine neoplasia syndromes. Clin Nucl Med, 2015, 40(7): e351-e356.
34. Lee I, Paeng JC, Lee SJ, et al. Comparison of diagnostic sensitivity and quantitative indices between⁶⁸Ga-DOTATOC PET/CT and ¹¹¹In-pentetreotide SPECT/CT in neuroendocrine tumors: a preliminary report. Nucl Med Mol Imaging, 2015, 49(4): 284-290.
35. Sharma P, Arora S, Dhull VS, et al. Evaluation of ⁶⁸Ga-DOTANOC PET/CT imaging in a large exclusive population of pancreatic neuroendocrine tumors. Abdom Imaging, 2015, 40(2): 299-309.
36. Ruf J, von Wedel F, Furth C, et al. Significance of a single-time-point somatostatin receptor SPECT/multiphase CT protocol in the diagnostic work-up of gastroenteropancreatic neuroendocrine neoplasms. J Nucl Med, 2016, 57(2): 180-185.
37. Arıcan P, Okudan Tekin B, Naldöken S, et al. A family with von Hippel-Lindau syndrome: the findings of indium-111 somatostatin receptor scintigraphy, iodine-123 metaiodobenzylguanidine scintigraphy and single photon emission computerized tomography. Mol Imaging Radionucl Ther, 2017, 26(1): 38-42.
38. Tshori S, Bocher M, Yuzefovich B, et al. Diagnostic computed tomography coregistration with In-111-DTPA-octreotide single photon emission tomography/low-dose computed tomography. J Comput Assist Tomogr, 2017, 41(3): 499-504.
39. Lee NJ, Hruban RH, Fishman EK. Pancreatic neuroendocrine tumor: review of heterogeneous spectrum of CT appearance. Abdom Radiol (NY), 2018, 43(11): 3025-3034.
40. Choi TW, Kim JH, Yu MH, et al. Pancreatic neuroendocrine tumor: prediction of the tumor grade using CT findings and computerized texture analysis. Acta Radiol, 2018, 59(4): 383-392.
41. Zhu L, Xue H, Sun H, et al. Insulinoma detection with MDCT: is there a role for whole-pancreas perfusion? AJR Am J Roentgenol, 2017, 208(2): 306-314.
42. Paiella S, Impellizzeri H, Zanolin E, et al. Comparison of imaging-based and pathological dimensions in pancreatic neuroendocrine tumors. World J Gastroenterol, 2017, 23(17): 3092-3098.
43. Tatsas AD, Owens CL, Siddiqui MT, et al. Fine-needle aspiration of intrapancreatic accessory spleen: cytomorphologic features and differential diagnosis. Cancer Cytopathol, 2012, 120(4): 261-268.
44. Atiq M, Bhutani MS, Bektas M, et al. EUS-FNA for pancreatic neuroendocrine tumors: a tertiary cancer center experience. Dig Dis Sci, 2012, 57(3): 791-800.
45. Mahajan R, Simon EG, Chacko A, et al. Endoscopic ultrasonography in pediatric patients—Experience from a tertiary care center in India. Indian J Gastroenterol, 2016, 35(1): 14-19.
46. Krishna SG, Bhattacharya A, Li F, et al. Diagnostic differentiation of pancreatic neuroendocrine tumor from other neoplastic solid pancreatic lesions during endoscopic ultrasound-guided fine-needle aspiration. Pancreas, 2016, 45(3): 394-400.
47. Bergeron JP, Perry KD, Houser PM, et al. Endoscopic ultrasound-guided pancreatic fine-needle aspiration: potential pitfalls in one institution’s experience of 1 212 procedures. Cancer Cytopathol, 2015, 123(2): 98-107.

Previous Article
真实场景与大数据下的整体微创理念，大幅提高结直肠癌远期生存率
Next Article
Research progress on gastrointestinal hemorrhage after cardiac surgery

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Mapping knowledge domains analysis of pancreatic neuroendocrine neoplasm research based on CiteSpace

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content